KAINOS MEDICINE operates in the Professional Services sector.
Legal name: KAINOS MEDICINE, INC.
In fiscal year 2025, KAINOS MEDICINE (284620) reported revenue of 1.2 billion KRW, up 98.5% from 590 million KRW a year earlier.
Operating profit was -6.4 billion KRW and net income was -7.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 36.0 billion KRW, with a P/B of 7.81.
These figures can be verified in the DART filing (receipt no. 20260323000993).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 1.2B | -6.4B | -7.8B |
| 2024 | 590M | -12.3B | -12.2B |
| 2023 | 267M | -16.8B | -15.2B |
Recent Filings
기타시장안내 (투자주의 환기종목 지정 사유 추가 관련 시장조치 미진)
Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
Semi-Annual Report (2026.06)
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | 기타시장안내 (투자주의 환기종목 지정 사유 추가 관련 시장조치 미진) |
| 2026-08-14 | Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B) |
| 2026-08-14 | Semi-Annual Report (2026.06) |